SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-015278
Filing Date
2023-08-28
Accepted
2023-08-28 08:00:31
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apge-20230630x10q.htm   iXBRL 10-Q 1515035
2 EX-2.1 apge-20230630xex2d1.htm EX-2.1 214183
3 EX-3.1 apge-20230630xex3d1.htm EX-3.1 60654
4 EX-3.2 apge-20230630xex3d2.htm EX-3.2 169875
5 EX-4.2 apge-20230630xex4d2.htm EX-4.2 266176
6 EX-10.2 apge-20230630xex10d2.htm EX-10.2 59761
7 EX-10.3 apge-20230630xex10d3.htm EX-10.3 60311
8 EX-10.4 apge-20230630xex10d4.htm EX-10.4 58185
9 EX-10.9 apge-20230630xex10d9.htm EX-10.9 168890
10 EX-31.1 apge-20230630xex31d1.htm EX-31.1 13767
11 EX-31.2 apge-20230630xex31d2.htm EX-31.2 12602
12 EX-32.1 apge-20230630xex32d1.htm EX-32.1 9849
  Complete submission text file 0001558370-23-015278.txt   6959271

Data Files

Seq Description Document Type Size
13 EX-101.SCH apge-20230630.xsd EX-101.SCH 48602
14 EX-101.CAL apge-20230630_cal.xml EX-101.CAL 21209
15 EX-101.DEF apge-20230630_def.xml EX-101.DEF 176742
16 EX-101.LAB apge-20230630_lab.xml EX-101.LAB 341799
17 EX-101.PRE apge-20230630_pre.xml EX-101.PRE 289436
68 EXTRACTED XBRL INSTANCE DOCUMENT apge-20230630x10q_htm.xml XML 771033
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41740 | Film No.: 231210306
SIC: 2836 Biological Products, (No Diagnostic Substances)